// App-Quantinova.ai

DOP072 : Achieving biochemical remission with adalimumab therapy using therapeutic drug monitoring: Results of a large prospective Crohn’s disease cohort

Researchers

Presenter

  • N Plevris

Principal Investigators

  • P Jenkinson

  • C S Chuah

  • M Lyons

  • R Hall

  • G Jones

  • E Watson

  • I Arnott

  • C Lees

Medical Centers

  • NHS Lothian, Gastroenterology, Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • Prospective

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved